ArticleFrontiers in pharmacology2023

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development.

Md Aminul Islam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.